Atervix

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Atervix

Quick Facts

Property Description
Active ingredient Clopidogrel bisulfate (INN: Clopidogrel)
Form Film-coated tablet
Pharmacological Class Antiplatelet Agent (P2Y12 Inhibitor)
General Purpose Prevention of unwanted blood clot formation
Origin Synthetic organic compound (Thienopyridine)
Prescribing Status Prescription-only medicine

Atervix: Identity, Composition, and Pharmacological Class

Atervix is a synthetic, prescription-only medicine containing clopidogrel (administered as clopidogrel bisulfate) as its single active ingredient. This substance is consistently formulated for oral administration in the form of a film-coated tablet. Clopidogrel is formally classified as an Antiplatelet Agent, a category of medication specifically designed to inhibit the function of blood platelets, a property that is clinically recognized for its role in secondary prevention. Clopidogrel, the active agent in Atervix, is the same ingredient found in other preparations, such as Plavix. This classification as an Antiplatelet Agent relates to the drug's role in targeting cellular elements of the clotting system to manage vascular health.

Mechanism and General Therapeutic Purpose

The core function of clopidogrel is rooted in its specialized action as a P2Y12 platelet aggregation inhibitor. This mechanism consists of the drug's effect of selectively and irreversibly modifying a specific receptor on the platelet surface. This action effectively renders platelets incapable of forming a clot for their remaining lifespan, which is a unique feature distinguishing thienopyridines like clopidogrel from reversible agents. By consistently reducing the blood's tendency to aggregate, the overarching general therapeutic purpose of Atervix is to reduce the risk of clot-related vascular blockages. A typical use scenario involves long-term management to prevent unwanted atherothrombotic events in adult patients.

Regulatory References

  1. National Institutes of Health (NIH)

What side effects are possible with Atervix?

Possible Side Effects and Safety Information for Atervix

Atervix (Clopidogrel) is associated with safety considerations centered on its antiplatelet activity, primarily the risk of bleeding and issues related to drug metabolism.

Key Safety Concerns

Classification Common Examples/Description (Frequency)
Serious & Life-Threatening Bleeding (gastrointestinal, intracranial), Thrombotic Thrombocytopenic Purpura (TTP) (rare, potentially fatal, characterized by fever, weakness, pale skin, and neurological symptoms), Severe Hypersensitivity Reactions (e.g., angioedema, anaphylaxis).
Common Adverse Reactions Bleeding (e.g., bruising, nosebleeds, hematoma), abdominal pain, dyspepsia, diarrhea.
Other Adverse Reactions Rare reports include severe liver disorders (acute liver failure), blood disorders (e.g., neutropenia, agranulocytosis), and cross-reactivity with other thienopyridine drugs.

Pharmacogenetic and Use-Related Safety Notes

  • Diminished Effectiveness (Boxed Warning): The U.S. FDA label includes a Boxed Warning regarding the drug's reduced antiplatelet effect in patients who are CYP2C19 poor metabolizers. These individuals do not effectively convert the drug to its active form, which may lead to higher cardiovascular event rates.
  • Contraindications: Atervix is contraindicated in patients with active pathological bleeding (e.g., peptic ulcer, intracranial hemorrhage) and in those with documented hypersensitivity to the drug substance.
  • Restrictions: Concomitant use with strong or moderate CYP2C19 inhibitors (such as omeprazole or esomeprazole) is discouraged as it can significantly reduce the antiplatelet effect. The drug should typically be discontinued five days before elective surgery with a major risk of bleeding. Premature discontinuation, however, increases the risk of cardiovascular events.

Overdose and Emergency Response

Overdose and when to seek help

Atervix overdose is documented in government regulatory labeling as an exaggeration of the drug’s established antiplatelet effect. The primary physiological consequence is a direct impact on the hemostatic system, manifested by a measurable prolongation of bleeding time and subsequent bleeding complications.

The most severe risks explicitly stated in official documents are severe hemorrhagic events, including gastrointestinal hemorrhage, which are classified as potentially life-threatening outcomes. Immediate medical help is required in all instances where an overdose is suspected or confirmed. Patients must seek immediate medical attention and contact emergency services if severe bleeding or other life-threatening symptoms occur.

The official regulatory profile states unequivocally that no specific antidote is known for clopidogrel overdose. Therefore, management is symptomatic and supportive. Supportive measures officially described may include the use of platelet transfusion to attempt to counteract the antiplatelet activity. Close observation and hospital monitoring are required following suspected overdose for continuous assessment. Official labeling does not define unique overdose manifestations specific to pediatric or elderly populations; general supportive principles apply.

Therapeutic Uses of Atervix

Quick Facts

  • Supportive care for acute coronary events: May be used as an option in managing recent myocardial infarction (MI) or stroke.
  • Reduction of vascular event risk: May contribute to reducing the risk of further MI or stroke in relevant patient populations.
  • Peripheral arterial disease: Considered as a therapeutic option for individuals with established peripheral arterial disease.

Atervix is a prescribed medication intended for use in patients who have experienced recent major cardiovascular events, or who have established conditions that present an increased risk of such events.

It is indicated for use in individuals who have experienced a recent myocardial infarction (heart attack) or a recent stroke caused by an inadequate blood supply to the brain. The medication may contribute to reducing the rate of recurrent MI and stroke in these patient groups. The treatment is also considered for use in patients with established peripheral arterial disease, a condition involving reduced blood flow in the arteries.

For patients presenting with acute coronary syndrome (a range of heart conditions including certain types of heart attack or severe chest pain), Atervix is typically used in conjunction with acetylsalicylic acid (aspirin) to offer potential benefit in managing the condition and may help limit the progression of vascular events.

Eligibility and Restrictions for Use

Eligibility for Atervix (Clopidogrel) Use

Official regulatory documents define specific populations who are eligible to use Atervix and those who are strictly prohibited. The medicine is primarily approved for use in adult patients with a history of recent myocardial infarction, recent stroke, or established peripheral arterial disease.

Absolute Contraindications

Atervix must not be used in patients with a state of active pathological bleeding, such as an intracranial hemorrhage or active peptic ulcer. It is also contraindicated in individuals with a known hypersensitivity to clopidogrel and in patients with severe hepatic impairment (severe liver disease).

Restrictions and Conditional Use

  • Age: Use is not established and should not be used in the pediatric population. Specific loading dose restrictions may apply to certain patients aged 75 years and older.
  • Organ Function: Caution is advised for use in patients with severe renal impairment. Individuals identified as CYP2C19 poor metabolizers have diminished response, and alternative treatment should be considered.
  • Physiological Status: During pregnancy, use is allowed only if clearly needed. For nursing mothers, the official label advises a decision to discontinue either nursing or the drug.

What should I know about interactions with other medicines?

Atervix (clopidogrel) can interact with several other medications and products, potentially affecting its effectiveness or increasing the risk of adverse effects, particularly bleeding. It is essential to inform your healthcare provider about all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are taking.

Increased Risk of Bleeding

The most significant risk of interaction involves medicines that also affect blood clotting. Combining Atervix with these products can further increase the risk of serious bleeding, especially in the stomach and intestines:

Drug Type Examples
Anticoagulants (Blood Thinners) Warfarin, Apixaban, Dabigatran
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Ibuprofen, Naproxen, Aspirin (other than low-dose prescribed by your doctor)
Other Antiplatelet Medicines Prasugrel, Ticagrelor
Certain Antidepressants Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Reduced Effectiveness of Atervix

Some medicines can interfere with the conversion of Atervix to its active form in the body, which may reduce its antiplatelet effect. This can make the medication less effective at preventing blood clots.

  • Proton Pump Inhibitors (PPIs): Strong inhibitors of the CYP2C19 enzyme, such as omeprazole and esomeprazole, should generally be avoided with Atervix. Your doctor may recommend a different PPI or an alternative anti-acid medication.
  • Opioids: Certain pain medications, including morphine, may reduce the absorption and effectiveness of Atervix. Separating the dosing of these medicines may be necessary.

If you are taking any medication that is known to interact with Atervix, your doctor will weigh the benefits and risks, and may adjust your dose or choose an alternative therapy.

Mechanism of Action

How Atervix Works

Targeting the P2Y12 Receptor and Irreversible Inhibition

The mechanism of Atervix begins with the prodrug that must first be chemically transformed by liver enzymes, primarily CYP2C19, into its active metabolite. This molecule then selectively and irreversibly blocks the P2Y12 receptor on the surface of blood platelets by forming a permanent covalent bond. This sustained receptor blockade inhibits the primary ADP-mediated signaling cascade, preventing the platelet's full activation.


Modulating Aggregation and The Platelet Lifespan

By disrupting the P2Y12 cascade, the drug prevents the platelet from activating the GPIIb/ IIIa complex, which is the final common pathway for platelet aggregation and cross-linking. The physiological consequence is a reduction in the blood's capacity to form platelet-rich thrombi. Because the P2Y12 receptor is permanently disabled, the anti-aggregatory effect persists for the entire 7–10 day lifespan of the affected platelet, with function only returning as new platelets are produced.


Mechanistic Variability Linked to CYP2C19

The drug's mechanism is intrinsically linked to the function of the CYP2C19 enzyme. Individuals with genetic variants, specifically reduced-function alleles (polymorphisms), metabolize the prodrug less efficiently. This results in reduced formation of the active metabolite, leading to a weaker P2Y12 blockade and, physiologically, a P2Y12 receptor blockade that is less complete.

Dosage and Administration Information

How to Use Atervix: Official Administration Guidelines

Atervix (clopidogrel) is a prescription-only medication administered exclusively by the oral route as a film-coated tablet. Its usage is structured around specific dosing rules, defining both the initial rapid treatment and the long-term maintenance pattern. Administration follows established principles for the appropriate use of the medication.


Dosing and Frequency

Usage Context Dosing Regimen Frequency and Duration
Maintenance (Established Conditions) 75 mg single tablet Once daily, for a long-term duration as determined by the treated condition.
Loading Dose (Acute Coronary Syndrome) 300 mg single tablet Followed immediately by the 75 mg once-daily maintenance dose, often for up to 12 months in combination with aspirin.

Administration Requirements

Administration of Atervix must be consistent and precise. The medicine may be taken with or without food, but must be taken at the same time each day to maintain a steady antiplatelet effect. In the event of a missed dose, if less than 12 hours have elapsed, the dose should be taken immediately; if more than 12 hours have passed, the missed dose should be skipped entirely, and the regular schedule resumed.

Population-Specific Use

Atervix is generally not recommended for use in the pediatric population. For older adults, specifically those over 75 years of age experiencing certain acute events (STEMI), treatment is initiated without a loading dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase III Clinical Trials

Research has explored whether the compound was associated with changes in liver function and blood sugar levels. Early investigations primarily focused on examining different concentrations of the compound for adult participants with type 2 diabetes.

  • Dose-Finding and Duration: The primary research evaluated whether a twice-daily administration schedule was associated with different observed effects compared to a once-daily administration schedule in metabolic control. The research examined effects observed over a 26-week period.
  • Food Interaction: Studies in participants evaluated the compound’s absorption when taken with food; some research explored whether the compound was associated with reported gastrointestinal events.
  • Long-Term Observations: One key study reported on the change in average HbA1c levels over a period of 12 months.

Key Efficacy Data

Studies explored the impact of the compound on various metabolic markers.

  • Glucose Management: Studies reported on the change in fasting plasma glucose levels and the change in postprandial glucose levels following treatment.
  • Lipid Profiles: Studies explored the compound’s association with changes in lipid profiles; trials observed changes in LDL cholesterol. Research also examined changes in triglyceride and HDL cholesterol levels.
  • Weight Management: A meta-analysis examining five placebo-controlled trials summarized the observed difference in participant body weight over a six-month period.

Subgroup Analysis

Research has examined the use of the compound in specific populations.

  • Kidney Impairment: Research has examined the use of the compound in individuals with severe kidney impairment. Some studies evaluated the compound’s effect on kidney function markers.
  • Combination Therapy: Research examined the combination of the compound with metformin and assessed the time to reported change in symptoms among newly diagnosed participants. Other studies explored the compound’s use alongside insulin and assessed the subsequent adjustment of insulin levels.
  • Lifestyle Factors: Studies evaluated the compound’s use in participants with type 2 diabetes and noted the participants' lifestyle factors during the research period.

Frequently Asked Questions (FAQ)

Common questions about Atervix (FAQ)


Q: How quickly does Atervix work to prevent [condition it treats]?

Official documents describe Atervix as a prodrug, meaning it must first be processed by liver enzymes into its active form to start working. The active form works by reducing the ability of platelets to clump together. Because this effect lasts for the life of the affected platelets (about 7 to 10 days), the full therapeutic effect takes time to achieve.


Q: How long after stopping Atervix does the drug stay in my system?

The drug's antiplatelet effect lasts for the entire lifespan of the platelets that have been affected, which is typically mathbf7 to mathbf10 days. For this reason, official guidelines often describe interrupting therapy about mathbf5 days prior to elective surgery that carries a major risk of bleeding.


Q: What is Atervix used for besides the main condition?

Regulatory documents state that Atervix is indicated to help reduce the rate of events such as heart attack and stroke. These uses apply to patients who have recently experienced acute coronary syndrome (ACS), recent heart attack (MI), recent stroke, or have established peripheral arterial disease (PAD).


Q: Is Atervix a blood thinner, and how is it different from aspirin?

Official information describes the medication as an antiplatelet agent, which is a specific type of medicine that helps prevent blood clots. Its function is to reduce the ability of platelets to clump together. It is often prescribed in combination with aspirin, which is also an antiplatelet agent.


Q: Are there any food or drinks I absolutely need to avoid while on Atervix?

Official drug information suggests using caution with grapefruit juice as it may cause interactions with the drug. Beyond that, no specific major food interactions are widely reported in the official regulatory documents. However, the drug may be taken with or without food.


Q: Can Atervix cause long-term damage to the liver or kidneys?

Official labeling notes that Severe hepatic impairment (severe liver problems) is a contraindication for use. Caution is also advised for patients who have existing severe renal (kidney) or hepatic (liver) impairment. These safety sections do not include a statement that the drug commonly causes long-term organ damage.


Q: Does Atervix affect my ability to drive or operate machinery?

Official safety summaries list potential side effects such as dizziness and headache. The possibility of these side effects means patients may wish to determine how the medication affects them before driving or operating complex machinery.


Q: Is Atervix safe to take alongside common pain relievers like Tylenol (acetaminophen)?

There are no known direct interactions between this drug and acetaminophen ( Tylenol) reported in official regulatory data. Official guidelines note that patients should not exceed the maximum recommended daily dosage of acetaminophen.


Q: Why is Atervix sometimes prescribed for a short time only?

Official information describes the drug being temporarily discontinued before certain medical procedures. This typically occurs prior to elective surgery that has a major risk of bleeding, and the drug is then restarted as soon as safely possible after the procedure.


Q: Are there generic versions of Atervix available?

Yes, the medication (clopidogrel) is available in generic versions approved by regulatory bodies like the FDA. Generic drugs are required to meet the same strict standards for quality, strength, and effectiveness as the original brand-name drug.


Q: Can men and women use Atervix the same way?

Official drug documents do not specify different standard dosing or administration requirements based on the patient's sex. The dosing regimens outlined in the official labeling are applied to the general adult population.


Q: Will taking Atervix make me bruise more easily?

Increased bruising is a common and expected effect of the medication. This occurs because Atervix works to reduce the ability of platelets to aggregate (clump), which is the drug's mechanism for preventing cardiovascular events.


Q: Is Atervix safe for people with a history of stomach ulcers?

Official regulatory labeling states that the drug is contraindicated (should not be used) in patients who have active pathological bleeding. This includes conditions like an active peptic ulcer or bleeding in the brain.


Q: Can I take Atervix with vitamins, supplements, or herbal products?

Official documents generally advise communicating with a healthcare provider about all prescription and non-prescription products they take, including vitamins, supplements, and herbal remedies. This is because some nonprescription products may interact with the drug.


Q: What are the signs of a severe allergic reaction to Atervix?

Signs of a severe allergic reaction listed in official documents may include hives, difficulty breathing or swallowing, swelling of the face, tongue, or throat, and hoarseness. These symptoms are listed as requiring immediate medical attention in the official labeling.


Q: Are there any long-term studies available on Atervix usage?

Yes, official approval for Atervix is based on clinical trials where the drug was studied over long-term periods. The prescribing information includes data from these trials to demonstrate the drug's effectiveness in reducing the rate of cardiovascular events in specific patient populations.


Q: Can people with diabetes or high blood pressure use Atervix?

These conditions are not listed as contraindications in the official regulatory labeling. The medication is often used in patient populations that also have these conditions, as they are not listed as absolute contraindications in the official labeling.


Q: How does Atervix affect my risk of bleeding during a minor surgery or dental procedure?

Atervix increases the risk of bleeding due to its antiplatelet effect. Official guidelines recommend interrupting therapy for mathbf5 days prior to elective surgery that has a major risk of bleeding. Procedures with minor risk are often managed differently.


Q: Does Atervix cause changes in mood or sleep patterns?

Official safety summaries primarily list physical side effects like headache and dizziness. While there is no direct mention of sleep or mood changes, severe side effects that include confusion are listed in rare cases.


Q: Can I use Atervix if I have a known allergy to other similar drugs?

Official warnings note that cross-reactivity has been reported among thienopyridines, which is the class of drugs Atervix belongs to. The warnings suggest that patients with an allergy to one thienopyridine drug may have a cross-reactivity risk with Atervix. Official information advises communicating any prior drug allergies to a healthcare professional.


Q: Can Atervix interact negatively with alcohol consumption?

There is no known direct drug interaction between Atervix and alcohol reported in official sources. However, official information notes that alcohol consumption may independently increase the risk of stomach bleeding, which could be compounded by the antiplatelet effect of the medication.


Q: Is Atervix a controlled substance?

Official regulatory classification indicates that this medication (clopidogrel) is mathbfnot a federally controlled substance in the United States.


Q: What does 'contraindication' mean regarding Atervix eligibility?

In official drug information, a contraindication means the drug should absolutely not be used because the risks outweigh any benefit. For Atervix, this specifically includes conditions like having active pathological bleeding, such as a peptic ulcer or a bleed in the brain.


Q: Does Atervix affect fertility or planning a pregnancy?

Official data derived from animal studies did not find evidence of impaired fertility. Regarding human use during pregnancy, data is limited, and use during labor or delivery may increase the risk of maternal bleeding.


Q: How is Atervix removed from the body?

Atervix is rapidly absorbed and metabolized by enzymes in the liver. The resulting drug metabolites are primarily eliminated from the body through the kidneys ( urine) and, to a lesser extent, in the feces.


Q: Why is it important to keep taking Atervix even if I feel fine?

Official warnings state that the premature discontinuation of the medication increases the risk of serious cardiovascular events, such as a heart attack or stroke. The drug is intended to reduce future risk, even if the patient is not currently experiencing symptoms.


Q: Are there specific genetic factors that affect how Atervix works?

Yes, official labeling notes that the drug's effectiveness depends on its conversion by the CYP2C19 liver enzyme. The label carries a Boxed Warning indicating that people with certain genetic variations may experience diminished drug activity, potentially making the drug less effective.


Q: Is Atervix meant to be a permanent treatment?

Official dosing information outlines a maintenance dose for a long-term duration as determined by the specific condition being treated. The required total duration of use is specific to the patient and their underlying cardiovascular risk.


Q: Can Atervix affect the results of common lab tests?

Regulatory data does not list any common laboratory tests known to directly interact with or be altered by the drug. However, the drug will affect specialized platelet function tests due to its antiplatelet mechanism.


Q: What percentage of people see an improvement using Atervix in studies?

Official approval is based on large-scale clinical trials. These studies demonstrated a statistically significant reduction in the rate of serious cardiovascular events (like heart attack or stroke) when compared to placebo in the specific patient populations studied.


Q: How often do people have to discontinue Atervix due to side effects?

The official prescribing information includes data from clinical trials reporting a specific rate of discontinuation due to adverse events. This information is available in the Adverse Reactions section of the product labeling.

How should Atervix be stored and disposed of?

Storage and Disposal of Atervix (Clopidogrel)

Atervix tablets must be stored at a Controlled Room Temperature, which is 25 C (77 F). The permitted temperature range for storage is strictly between 15 C and 30 C (59 F and 86 F).

Storage Requirements

  • Container: Keep the tablets in their original packaging and, if supplied in a bottle, ensure the container is tightly closed to maintain product integrity.
  • Child Safety: This and all medications must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Atervix must be disposed of according to local regulatory requirements. The preferred method is using an authorized medicine take-back program. It is generally prohibited to dispose of the tablets via household waste or by flushing them into wastewater, as clopidogrel may pose a risk to the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atervix found in:

A-Z Index: